Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 355 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Triglyceride Clear all

Conditions: Relapsing Remitting MS, Secondary Progressive MS, Primary Progressive MS
Interventions: Caprylic Triglyceride, Placebo; Dietary Supplement
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 59 Years
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Hyperlipidemias, Cardiovascular Diseases
Interventions: Dried blood spot testing and phlebotomy; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Recurrent Urinary Tract Infection, Postmenopause, Postmenopausal Syndrome, Postmenopausal Symptoms, Menopause
Interventions: Prasterone, Placebo; Drug
Lead sponsor: Olivia Cardenas-Trowers, M.D.; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Parenteral Nutrition Associated Liver Disease (PNALD), Essential Fatty Acid Deficiency, Malnutrition, Pediatric ALL
Interventions: Omegaven® (fish oil triglycerides) Injectable Emulsion; Drug
Lead sponsor: Fresenius Kabi; Industry
Eligibility: 1 Day to 17 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 10
States / cities: Fountain Valley, California • Los Angeles, California • Chicago, Illinois + 7 more

Conditions: Drug-induced Weight Gain
Interventions: RDX-002 + Olanzipine, Olanzapine; Drug
Lead sponsor: Response Pharmaceuticals; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Triglycerides
Interventions: Curcumin (Longvida™), Half Dose Curcumin (Longvida™), Astaxanthin, Placebo Control; Dietary Supplement · Other
Lead sponsor: Medinutra LLC; Other
Eligibility: 21 Years to 59 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Dublin, Ohio

Conditions: Pediatric Sepsis
Interventions: For group Peds Sep A: Standard nutrition will be given, For Group Peds SepB: Low leucine, isoleucine formula, For Group Peds Sep C: Medium chain triglyceride oil enriched formula., For Group Peds Sep D: Low carbohydrate ketogenic formula; Dietary Supplement
Lead sponsor: University of Pittsburgh; Other
Eligibility: 44 Weeks to 17 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease, Prediabetic State, Obesity
Interventions: Placebo, Diazoxide Oral Suspension, 2 mg per kg per dose, Deuterated water (2H2O/D2O), 70%, Insulin Suppression Test (IST); Drug · Diagnostic Test
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy
Interventions: Dr Pepper sweetened with sucrose or high fructose corn syrup; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cancer, Hepatic Injury
Interventions: Omegaven; Drug
Lead sponsor: Midwestern Regional Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Zion, Illinois

Conditions: Bioavailability
Interventions: Oxandrin; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Asthma
Interventions: DGA Diet, MCT Diet, KETO Diet; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Hypo-unawareness, Type 1 Diabetes Mellitus
Interventions: Medium chain triglycerides; Dietary Supplement
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Cardiovascular Diseases, Vascular Disease, Inflammation, Insulin, Triglycerides
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV Infections
Interventions: ATV/r, DRV/r; Drug
Lead sponsor: Community Research Initiative of New England; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 11
States / cities: Phoenix, Arizona • Los Angeles, California • Orlando, Florida + 7 more

Conditions: Combined Hyperlipidemia
Interventions: Pravafen, Pravastatin, Fenofibrate; Drug
Lead sponsor: Shionogi; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 481 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 57
States / cities: Phoenix, Arizona • Sierra Vista, Arizona • Long Beach, California + 46 more

Conditions: Healthy
Interventions: AC-1204, caprylic triglyceride oil (standard breakfast), caprylic triglyceride oil (high fat breakfast); Drug
Lead sponsor: Cerecin; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Alzheimer's Disease, Oxidative Stress, Dementia, Hyperlipidemia, Inflammation
Interventions: Fish Oil, Lipoic Acid, Fish Oil Placebo, Lipoic Acid Placebo; Dietary Supplement · Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 55 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Hyperlipidemia
Interventions: MCT oil + Butter in Coffee; Dietary Supplement
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years to 45 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cholestasis
Interventions: Omegaven; Drug
Lead sponsor: Carle Foundation Hospital; Other
Eligibility: 14 Days to 4 Months
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Pulmonary; Hypertension, Steatosis, Right Ventricular Failure
Interventions: Omega-3 fatty acids; Dietary Supplement
Lead sponsor: Wen-Chih Wu; Federal
Eligibility: 30 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Diet Modification, Cardiology
Interventions: whole food, plant based diet; Behavioral
Lead sponsor: Lancaster General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Lancaster, Pennsylvania

Conditions: Liver Disease, Impaired Liver Function, Parenteral Nutrition Associated Liver Disease
Interventions: Omegaven; Drug
Lead sponsor: Children's Medical Center Dallas; Other
Eligibility: 2 Months to 10 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypertriglyceridemia
Interventions: Omega-3-acid ethyl esters, Placebo; Drug
Lead sponsor: Babu Balagopal; Other
Eligibility: 10 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 3
States / cities: Wilmington, Delaware • Baltimore, Maryland • Philadelphia, Pennsylvania

Search by objective public record fields.

Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

Dried Blood Spot- Statin Pilot Study

Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Effect of RDX-002 on Postprandial Triglycerides in Subjects Treated With Olanzapine

Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation

Personalized Metabolic Nutrition Sepsis Study

Effect of Insulin Lowering on Lipogenesis

Pharmacokinetics and Pharmacodynamics of Fructose

Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Oxandrolone in Healthy Adults: A Relative Bioavailability Study

Nutrition for Asthmatics

Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.

Effect of Diet on Vascular Disease in Pre-Menopausal Women

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia

Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production

Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease

Effect of Butter & MCT Oil on Lipoproteins - A RCT

Omegaven® as Parenteral Nutrition

Reversal of Right Ventricular Steatosis in Pulmonary Hypertension

A Whole Food Plant Diet and Its Lipidemic Effects on Primary Prevention in a Free-range Population

Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Fish Oil Study for High Triglyceride Levels in Children